seed
Stage
2020
Founded
2
Investors
About
Orikine Bio is a biotechnology company developing precision-engineered, bi‑specific cytokine therapies (Foldikine™ platform) to treat severe autoimmune and inflammatory diseases by reprogramming immune signalling for improved efficacy and safety.
Explore Orikine Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.